Metformin: An Old Dog with a New Trick?
Level V
Where this comes from
- Record sourced from PubMed, PMID 30184483.
- Also identified by DOI 10.1016/j.cmet.2018.08.018.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Idiopathic pulmonary fibrosis (IPF) remains an important medical challenge, but recent translational data have provided clues implicating deficient AMPK signaling in persistently activated myelofibroblasts within fibrotic foci. A new study in Nature Medicine reports that pharmacological activation of AMPK with metformin can reverse established fibrosis by facilitating deactivation and apoptosis of myofibroblasts.
Medical subject headings
- Idiopathic Pulmonary Fibrosis
- Metformin